Hall A · Booth A207

UnionStrong (Beijing) Technology Co., Ltd.

Registered Chinese name强联智创(北京)科技股份有限公司UnionStrong (Beijing) Technology Co., Ltd.

Qianglian Zhichuang (Beijing) Technology Co., Ltd. was established in 2016. It is a pioneer and leading company in the field of AI diagnosis and treatment of neurovascular diseases…

Smart surgical solutions for neurovascular diseases
Robot OEMs & Systems

Company Profile

Qianglian Zhichuang (Beijing) Technology Co., Ltd. was established in 2016. It is a pioneer and leading company in the field of AI diagnosis and treatment of neurovascular diseases in China, focusing on creating full-stack AI medical solutions. The company has long been working with a number of national neurological disease medical centers to carry out collaborative innovation, and has strong technical strength. It currently has nearly 150 authorized patents, nearly 50 software copyrights and multiple scientific research achievements. It has been rated as a national-level "Key Little Giant" for specialization, a national intellectual property advantage enterprise and other qualifications. With "DEEP AI for NEURO" as its core, the company has built a product and service system that runs through the entire process of diagnosis, evaluation, surgery, and patient management, and covers all scenarios of clinical diagnosis and treatment, doctor training, medical research, and patient education. The company will continue to rely on its self-developed core product UMate™ series of AI catheter shaping robots to build the world's leading intelligent diagnosis and treatment service platform for neurovascular diseases.

Key Products

01 ITEMS
Smart surgical solutions for neurovascular diseases
01

Smart surgical solutions for neurovascular diseases

Qianglian Zhichuang® cooperates with Huashan Hospital Affiliated to Fudan University and Xuanwu Hospital of Capital Medical University to develop intelligent surgical solutions for neurovascular diseases, which are original, original research and origin in China. Based on patient imaging data, the solution uses a patented AI algorithm to complete 3D vascular reconstruction, automatic measurement and personalized catheter shaping planning, and combines the robot's "micro-finger" and "micro-delivery" technology to achieve micron-level automatic catheter shaping and simulated release of consumables, improving surgical efficiency and safety, and reducing the risk of recurrence and complications.